3-Cyclopentene-1-butanol, beta,2,2,3-tetramethyl-
Common Name: |
3-Cyclopentene-1-butanol, beta,2,2,3-tetramethyl- |
IUPAC Name: |
2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)butan-1-ol |
Molecular Formula: |
C13H24O |
SMILES: |
CC1=CCC(C1(C)C)CCC(C)CO |
Inchi: |
1S/C13H24O/c1-10(9-14)5-7-12-8-6-11(2)13(12,3)4/h6,10,12,14H,5,7-9H2,1-4H3 |
Inchi Key: |
CYVGAJHMMVDTDZ-UHFFFAOYSA-N |
Cas No: |
72089-08-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
196.33 |
Mass (g/mol) |
196.183 |
Molar Refractivity |
62.92 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
262.00 to 263.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.002 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.85 |
LogP |
3.387 |
iLOGP |
3.04 |
XLOGP3 |
3.44 |
WLOGP |
3.39 |
MLOGP |
3.15 |
ESOL Log S |
-2.96 |
ESOL Solubility (mg/ml) |
0.215 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.55 |
Ali Solubility (mg/ml) |
0.06 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.02 |
Silicos-IT Solubility (mg/ml) |
0.19 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.06 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.506 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.096 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |